AKAN - AKANDA CORP.
1.16
-0.043 -3.733%
Share volume: 20,355
Last Updated: 05-09-2025
Pharmaceutical Products/Medicinal Chemicals:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$1.20
-0.04
-0.04%
Summary score
63%
Profitability
50%
Dept financing
25%
Liquidity
0%
Performance
100%
Sector
Manufacturing
Industry
Pharmaceutical Products/Medicinal Chemicals
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | AKAN | TCNNF | CRON | TLRY |
---|---|---|---|---|
Return on equity | 0% | 0% | 5.03% | 0% |
Return on assets | 0% | 0% | -1.02% | 0% |
Return on sales | 0% | 0% | -247.06% | 0% |
Return on invested capital | 0% | 0% | 81.83% | 0% |
Profitability | 50% | 0% | 50% | 0% |
Total debt ratio | 0% | 0% | 19.81% | 0% |
Debt ratio change over time | 0% | 0% | -2.04% | 0% |
Dept financing | 25% | 0% | 25% | 0% |
Current Ratio | 0% | 0% | 5.28% | 0% |
Quick Ratio | 0% | 0% | 5.11% | 0% |
Cash Position Ratio | 0% | 0% | 5.02% | 0% |
Liquididy | 0% | 0% | 75% | 0% |
Short-term ratios | AKAN | TCNNF | CRON | TLRY |
---|---|---|---|---|
Return on equity | 0% | 0% | 4.7% | 0% |
Return on assets | 0% | 0% | -1.49% | 0% |
Return on sales | 0% | 0% | -563.12% | 0% |
Return on invested capital | 0% | 0% | 220.39% | 0% |
Profitability | 50% | 0% | 50% | 0% |
Total debt ratio | 0% | 0% | 15.56% | 0% |
Debt ratio change over time | 0% | 0% | -1.14% | 0% |
Dept financing | 25% | 0% | 25% | 0% |
Current Ratio | 0% | 0% | 5.28% | 0% |
Quick Ratio | 0% | 0% | 5.11% | 0% |
Cash Position Ratio | 0% | 0% | 5.02% | 0% |
Liquididy | 0% | 0% | 75% | 0% |